VK

Venu Kumar Ankam

Director Director DIN 08730617
DIN 08730617 First appointment Apr 2020 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Venu Kumar Ankam

Data last updated:

Venu Kumar Ankam was a Director at Sunoxy Pharma Private Limited (2022–2023) and Director at Sunops Pharma Private Limited (from 2020). The companies operate in Trading.

DIN 08730617
Primary Designation Director
Industry Trading
First Appointment 15 Apr 2020
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunoxy Pharma Private Limited U51909KA2022PTC163471
Director06 Jul 20222022Active
Sunops Pharma Private Limited U24232KA2020PTC133775
Director15 Apr 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sunops Pharma Private Limited
Sunoxy Pharma Private Limited
Premium access

Shareholding and investment profile for Venu Kumar Ankam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venu Kumar Ankam

Venu Kumar Ankam was first appointed on 15 Apr 2020 as Director at Sunops Pharma Private Limited. The most recent appointment on record is 06 Jul 2022 at Sunoxy Pharma Private Limited.

Venu Kumar Ankam held 2 earlier board appointments: Sunoxy Pharma Private Limited (Director, 06 Jul 2022 to 15 May 2023); Sunops Pharma Private Limited (Director, from 15 Apr 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available